AdvaMed Speaks Out on "Comparative Effectiveness" PolicyAdvaMed Speaks Out on "Comparative Effectiveness" Policy

The full list of principles can be found here.At a press teleconference this afternoon, AdvaMed President Stephen Ubl said the organization has three key points:1. Comparative effectiveness data can have value, but individual judgements for individual decisions must remain.2. Any decision-making process that incorporates comparative effectiveness data should focus on clinical effectiveness instead of cost effectiveness. Otherwise, patients might have to undergo treatments that are cost effective but clinically inferior.3. All stakeholders -- industry, doctors, patients, payors -- need to have input into these policies.